Showing results (441-450 of 1,401) with videos related to
Sort By:
Pageof 141
Pharmacology Research & Perspectives|February 19, 2015
Varenicline enhances dopamine release facilitation more than nicotine after long-term nicotine treatment and withdrawalXiomara A Perez, Taline V Khroyan, J Michael McIntosh, et al.Pharmacology Research & Perspectives|August 21, 2020
Adverse pregnancy outcomes associated with first-trimester exposure to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers: A systematic review and meta-analysisNida Buawangpong, Supanimit Teekachunhatean, Nut KoonrungsesomboonPharmacology Research & Perspectives|April 20, 2023
Computational design and molecular modeling of morphine derivatives for preferential binding in inflamed tissueMakena Augenstein, Nayiri Alexander, Matthew GartnerPharmacology Research & Perspectives|June 26, 2020
Characterization of T-DM1-resistant breast cancer cellsJuliette Sauveur, Louise Conilh, Sabine Beaumel, et al.Pharmacology Research & Perspectives|July 28, 2020
Hypothesis: Pentoxifylline is a potential cytokine modulator therapeutic in COVID-19 patientsBruce M Hendry, Nina Stafford, Ahran D Arnold, et al.Pharmacology Research & Perspectives|November 6, 2019
Azelastine potentiates antiasthmatic dexamethasone effect on a murine asthma modelCarlos D Zappia, Ariadna Soto, Gina Granja-Galeano, et al.Pharmacology Research & Perspectives|December 18, 2019
Individualized medicine: Sex, hormones, genetics, and adverse drug reactionsAnn M Moyer, Eric T Matey, Virginia M MillerPharmacology Research & Perspectives|November 27, 2019
Pharmacological plasticity-How do you hit a moving target?Michael J Parnham, Gerd GeisslingerPharmacology Research & Perspectives|November 26, 2019
Identification of repurposable drugs with beneficial effects on glucose control in type 2 diabetes using machine learningGideon Koren, Galia Nordon, Kira Radinsky, et al.Pharmacology Research & Perspectives|November 26, 2019
Species differences in ocular pharmacokinetics and pharmacological activities of regorafenib and pazopanib eye-drops among rats, rabbits and monkeysShinya Horita, Miwa Watanabe, Mai Katagiri, et al.Pageof 141